Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors (Q35047221)

6 August 2017

1 reference

title

Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors (English)

1 reference

6 August 2017

0 references

2

Myron M Levine

1 reference

6 August 2017

1

Marcela F Pasetti

1 reference

6 August 2017

Marcelo B Sztein

3

1 reference

PubMed ID

12531639

6 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

6 August 2017

18

1 reference

inferred from page(s)

published in

Vaccine

1 reference

6 August 2017

21

1 reference

6 August 2017

401-418

1 reference

6 August 2017

5-6

1 reference

Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Bacterial systems for the delivery of eukaryotic antigen expression vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Salmonella vaccines for use in humans: present and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Salmonella: immune responses and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Typhoid fever--important issues still remain

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Typhoid fever: pathogenesis and immunologic control

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Host-Salmonella interaction: human trials

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Studies on infection and immunity in experimental typhoid fever. I. Typhoid fever in chimpanzees orally infected with Salmonella typhosa

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

The route of enteric infection in normal mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

OBSERVATIONS ON EXPERIMENTAL TYPHOID INFECTION OF THE GALL BLADDER IN THE RABBIT.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Anatomical and immunological responses of rabbit gallbladders to bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Salmonellosis: host immune responses and bacterial virulence determinants.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Immune response to infection with Salmonella typhimurium in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Animal models of Salmonella infections: enteritis versus typhoid fever.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Immunity to systemic Salmonella infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Salmonella interactions with host cells: in vitro to in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Immune responses to intracellular bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Salmonella interactions with host cells: type III secretion at work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Salmonella: a model for bacterial pathogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

The invasion-associated type-III protein secretion system in Salmonella--a review

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

How Salmonella became a pathogen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Live attenuated Salmonella: a paradigm of mucosal vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Immune response to Salmonella: location, location, location?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

The role of M cells in Salmonella infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

The role of dendritic cells during Salmonella infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Murine salmonellosis studied by confocal microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect on phagocytes in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Intracellular replication of Salmonella typhimurium strains in specific subsets of splenic macrophages in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

A recombinant Salmonella typhimurium vaccine strain is taken up and survives within murine Peyer's patch dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

In vivo activation of dendritic cells and T cells during Salmonella enterica serovar Typhimurium infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Salmonella infection of bone marrow-derived macrophages and dendritic cells: influence on antigen presentation and initiating an immune response.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Antigen presentation capacity and cytokine production by murine splenic dendritic cell subsets upon Salmonella encounter

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Role of T cells, TNF alpha and IFN gamma in recall of immunity to oral challenge with virulent salmonellae in mice vaccinated with live attenuated aro- Salmonella vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Host cytokine response and resistance to Salmonella infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Intracellular pathogens: the role of antibody-mediated protection in Salmonella infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Adoptive transfer of immunity to oral challenge with virulent salmonellae in innately susceptible BALB/c mice requires both immune serum and T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Cutting edge: role of B lymphocytes in protective immunity against Salmonella typhimurium infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Antibody is required for protection against virulent but not attenuated Salmonella enterica serovar typhimurium

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Igh-6(-/-) (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Protective immunity induced by outer membrane proteins of Salmonella typhimurium in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Influence of the Ity gene on salmonella infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Structure and function of the natural-resistance-associated macrophage protein (Nramp1), a candidate protein for infectious and autoimmune disease susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

The Nramp1 protein and its role in resistance to infection and macrophage function.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

The natural resistance-associated macrophage protein and susceptibility to intracellular pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Essential role of MD-2 in LPS responsiveness and TLR4 distribution.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Host resistance to infection: genetic control of lipopolysaccharide responsiveness by TOLL-like receptor genes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Salmonella infections in the absence of the major histocompatibility complex II.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Immunity to Salmonella infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Natural history of oral Salmonella dublin infection in BALB/c mice: effect of an 80-kilobase-pair plasmid on virulence.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Polymorphonuclear leukocytes and innate immunity to Salmonella infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Typhoid fever: pathogenesis and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Duodenal string cultures: practicality and sensitivity for diagnosing enteric fever in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Efficacy of bone marrow, blood, stool and duodenal contents cultures for bacteriologic confirmation of typhoid fever in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Genes of the class II and class III major histocompatibility complex are associated with typhoid fever in Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Typhoid fever and genetic polymorphisms at the natural resistance-associated macrophage protein 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

The serodiagnosis of infection with Salmonella typhi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Vi serology in detection of chronic Salmonella typhi carriers in an endemic area

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Experience with Salmonella typhi Vi capsular polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Salmonella typhi flagella are potent inducers of proinflammatory cytokine secretion by human monocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Exploiting the immune system: toward new vaccines against intracellular bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Vaccination for control of Salmonella in poultry

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Experimental Salmonella typhi infection in the domestic pig, Sus scrofa domestica

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

The dissemination of Salmonella typhi, S. paratyphi A and S. paratyphi B through the organs of the white mouse by oral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Assessment of Typhoid Vaccines by Using the Intraperitoneal Route of Challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Innate resistance of mice to Salmonella typhi infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

A possible mechanism for host-specific pathogenesis of Salmonella serovars

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Expression of host resistance to Salmonella typhi and Salmonella typhimurium: bacterial survival within macrophages of murine and human origin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Construction of genetically defined double aro mutants of Salmonella typhi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Construction of defined galE mutants of Salmonella for use as vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

The RcsB-RcsC regulatory system of Salmonella typhi differentially modulates the expression of invasion proteins, flagellin and Vi antigen in response to osmolarity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Attenuated deltaguaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Aromatic-dependent salmonella as anti-bacterial vaccines and as presenters of heterologous antigens or of DNA encoding them

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Recombinant liveSalmonellaspp. for human vaccination against heterologous pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Elicitation of predictable immune responses by using live bacterial vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Mucosal immunity to infection with implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Use of live bacterial vaccine vectors for antigen delivery: potential and limitations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Kinetics of the mucosal antibody secreting cell response and evidence of specific lymphocyte migration to the lung after oral immunisation with attenuated S. enterica var. typhimurium.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

A comparison of immunogenicity and in vivo distribution of Salmonella enterica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Vaccination against bubonic and pneumonic plague

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Delivery of epitopes by the Salmonella type III secretion system for vaccine development.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Oral immunization with a Salmonella typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Expression, extracellular secretion, and immunogenicity of the Plasmodium falciparum sporozoite surface protein 2 in Salmonella vaccine strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Effect of attenuated Salmonella enterica serovar Typhimurium expressing a Streptococcus mutans antigen on secondary responses to the cloned protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Nasal vaccination with attenuated Salmonella typhimurium strains expressing the Hepatitis B nucleocapsid: dose response analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Salmonella vaccines secreting measles virus epitopes induce protective immune responses against measles virus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Induction of specific CD8+ memory T cells and long lasting protection following immunization with Salmonella typhimurium expressing a lymphocytic choriomeningitis MHC class I-restricted epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

The immune response to a B-cell epitope delivered by Salmonella is enhanced by prior immunological experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Immunity induced by live attenuated Salmonella vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Protection against murine listeriosis by oral vaccination with recombinant Salmonella expressing hybrid Yersinia type III proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Immunisation with Salmonella typhimurium-delivered glyceraldehyde-3-phosphate dehydrogenase protects mice against challenge infection with Echinococcus multilocularis eggs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Nramp1 transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on antigen processing and presentation.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Effect of the mouse Nramp1 genotype on the expression of IFN-gamma gene in early response to Salmonella infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Genetic control of antibody responses induced against an antigen delivered by recombinant attenuated Salmonella typhimurium

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Intracellular bacteria as targets and carriers for vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Construction and evaluation of an expression vector allowing the stable expression of foreign antigens in a Salmonella typhimurium vaccine strain.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Mixed population approach for vaccination with live recombinant Salmonella strains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Oral vaccination against tetanus: comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Vectors to achieve selective expression of vaccine antigens within eukaryotic cells using Salmonella spp. as carrier strains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

In vivo visualization of bacterial colonization, antigen expression, and specific T-cell induction following oral administration of live recombinant Salmonella enterica serovar Typhimurium

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Expression of the Plasmodium falciparum immunodominant epitope (NANP)(4) on the surface of Salmonella enterica using the autotransporter MisL

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Impact of intracellular location of and antigen display by intracellular bacteria: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Enhancement of the specific mucosal IgA response in vivo by interleukin-5 expressed by an attenuated strain of Salmonella serotype Dublin.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Cytokine expression by attenuated intracellular bacteria regulates the immune response to infection: the Salmonella model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Effect of preexisting immunity to Salmonella on the immune response to recombinant Salmonella enterica serovar typhimurium expressing a Porphyromonas gingivalis hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Oral delivery of foreign antigens by attenuated Salmonella: consequences of prior exposure to the vector strain.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Construction and immunogenicity in mice of attenuated Salmonella typhi expressing Plasmodium falciparum merozoite surface protein 1 (MSP-1) fused to tetanus toxin fragment C.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Salmonella enterica serovar Typhi live vector vaccines delivered intranasally elicit regional and systemic specific CD8+ major histocompatibility class I-restricted cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Novel use of anaerobically induced promoter, dmsA, for controlled expression of fragment C of tetanus toxin in live attenuated Salmonella enterica serovar Typhi strain CVD 908-htrA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Surface-displayed viral antigens on Salmonella carrier vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Induction of antibody-secreting cells and T-helper and memory cells in murine nasal lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Nasal vaccination using live bacterial vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Immunomodulators and delivery systems for vaccination by mucosal routes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

1 reference

7 January 2021

Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Immunogenicity of a candidate live oral typhoid/cholera hybrid vaccine in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Bacterial virulence, proinflammatory cytokines and host immunity: how to choose the appropriate Salmonella vaccine strain?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Can a 'flawless' live vector vaccine strain be engineered?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Expression of disulphide-bridge-dependent conformational epitopes and immunogenicity of the carboxy-terminal 19 kDa domain of Plasmodium yoelii merozoite surface protein-1 in live attenuated Salmonella vaccine strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Bacteria as gene delivery vectors for mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Delivery of DNA vaccines by attenuated intracellular bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Oral somatic transgene vaccination using attenuated S. typhimurium.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

In vivo correction of genetic defects of monocyte/macrophages using attenuated Salmonella as oral vectors for targeted gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Tyrosine hydroxylase-based DNA-vaccination is effective against murine neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Oral transgene vaccination mediated by attenuated Salmonellae is an effective method to prevent Herpes simplex virus-2 induced disease in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Transgene as vaccine for chlamydia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Unique immunogenicity of hepatitis B virus DNA vaccine presented by live-attenuated Salmonella typhimurium.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Prothymosin alpha enhances protective immune responses induced by oral DNA vaccination against pseudorabies delivered by Salmonella choleraesuis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Recombinant attenuated bacteria for the delivery of subunit vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Introduction of protein or DNA delivered via recombinant Salmonella typhimurium into the major histocompatibility complex class I presentation pathway of macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Use of lambda phage S and R gene products in an inducible lysis system for Vibrio cholerae- and Salmonella enterica serovar typhimurium-based DNA vaccine delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900472-3

7 January 2021

10.1016/S0264-410X(02)00472-3

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12531639